放射治療/放射性藥物/核子醫學：全球市場

Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

出版日期: 2024年07月05日 | 出版商:

BCC Research | 英文 119 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球放射治療、放射性藥物和核醫市場規模預計將從 2024 年的175 億美元增加到 2029 年底的 313 億美元，預測期內複合年成長率為 12.3%。

放射性藥物產業預計將從 2024 年的 99 億美元成長到 2029年終的210 億美元，複合年成長率為 16.2%。此外，預計到 2029年終，放射治療產品和服務業將從 2024 年的 75 億美元增加到 102 億美元，複合年成長率為 6.3%。

本報告調查了全球放射治療、放射性藥物和核醫市場，並提供了市場概況、市場影響因素和市場機會分析、新興技術和技術發展趨勢、市場規模趨勢和預測、各種分類、詳細總結區域分析、競爭格局和主要企業概況。

細分細分
放射治療市場：依產品類型
市場概況
市場規模/預測
放射治療市場：依技術類型
市場規模/預測
外部放射治療
EBRT：依技術型
EBRT：依系統型
EBRT：依申請
內部放射治療
IBRT：依技術型
IBRT：依產品類型
IBRT：按申請
放射治療市場：按地區
市場規模/預測
北美洲
歐洲
亞太地區
其他地區
放射性藥物市場：依產品類型
市場規模/預測
診斷放射性藥物
治療性放射性藥物
放射性藥物市場：依應用分類
市場規模/預測
瘤
心臟病
神經
其他
放射性藥物市場：依製造方法分類
市場概況
核子反應爐
迴旋加速器
放射性核種產生器
市場規模/預測
地域分佈
放射性藥物市場：按地區
市場規模/預測
北美洲
歐洲
亞太地區
其他地區

第6章競爭訊息

放射治療設備主要製造商
主要企業

第7章附錄

調查方法
來源
簡稱
公司簡介
ACCURAY INC.
CARDINAL HEALTH
CURIUM
ELEKTA
GE HEALTHCARE
LANTHEUS
NOVARTIS AG
SIEMENS HEATHNIEERS AG

簡介目錄圖表

Product Code: HLC176E

The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.

The global market for radiopharmaceuticals is expected to grow from $9.9 billion in 2024 and is projected to reach $21.0 billion by the end of 2029, at a CAGR of 16.2% during the forecast period of 2024 to 2029.

The global market for radiation therapy products and services is expected to grow from $7.5 billion in 2024 and is projected to reach $10.2 billion by the end of 2029, at a CAGR of 6.3% during the forecast period of 2024 to 2029.

Report Scope

This report analyzes the global market for radiation therapy products (systems, software and services) and radiopharmaceuticals, in terms of quantitative and qualitative data, to help readers develop assess the market, business/growth strategies, and make informed business decisions regarding radiation therapy products and services and radiopharmaceuticals. BCC Research estimates market data for 2023 (the base year) and forecasts values for 2024 through 2029.

Radiation therapy market segmentation is based on product, technology, techniques, system type, application and region. Radiopharmaceuticals market segmentation is based on product, application, production method and region.

Industry growth drivers, restraints and opportunities in the radiation therapy and radiopharmaceutical market are also discussed. The report also reports on the competitive landscape of radiation therapy products, radiopharmaceutical markets and emerging trends. The latest new products, acquisitions, and collaborations related to the radiation therapy and radiopharmaceutical markets are also covered.

Report Includes

51 data tables and 39 additional tables
An overview of the global market for radiotherapy, radiopharmaceuticals and nuclear medicines
Analysis of global market trends, featuring historical revenue data for 2021-2023, estimated figures for 2024, forecasts for 2025, and projected CAGRs through 2029
Identification of new opportunities, challenges and technological changes in the industry and a market share analysis by segment, product type, technology type, application, production method, and region
Examination of the present and future strategies of companies in the market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
Discussion of the applications for positron emission tomography (PET) and single photon emission computed tomography (SPECT)
Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
Analysis of the current market trends and forecast, R&D activity, product launches and regulatory elements
Analysis of the key companies' market shares, mergers & acquisitions, joint ventures and collaborations
Profiles of the major players in the market, including Accuray Inc., Cardinal Health, Elekta, Novartis AG, and Siemens Healthineers AG

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Radiopharmaceuticals
Radiation Therapy

Chapter 3 Market Dynamics

Radiotherapy Market Drivers
Rising Prevalence of Cancer
Early Screening
Advances in Radiation Therapy Planning and Delivery Systems
Increasing Demand in Developing Regions
Applications Beyond Oncology
Radiotherapy Market Restraints
Shortage of Skilled Professionals
Limited Effectiveness against Metastatic Cancer
Trends in Radiotherapy Market
Growing Use of Advanced Imaging and Hypofractionation
Adaptive Radiation Therapy
Radiopharmaceutical Market Drivers
Rising Prevalence of Chronic Diseases
Focus on Early Diagnosis and Screening
Precision Medicine
Nuclear Imaging Technologies
Increasing Investments
Radiopharmaceutical Market Restraints
Manufacturing and Supply Chain Issues
Infrastructure and Specialized Imaging Equipment Requirements
Trends in the Radiopharmaceutical Market
Theranostics
PET/MRI Hybrid Imaging

Chapter 4 Emerging Technologies and Developments

Emerging Technologies in Radiation Therapy
Artificial Intelligence
Online Adaptive Radiation Therapy
MR-Linac
FLASH Radiation Therapy
Emerging Technologies in Radiopharmaceuticals
Targeted Alpha Therapy

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown
Radiation Therapy Market, by Product Type
Market Overview
Market Size and Forecast
Radiation Therapy Market, by Technology Type
Market Size and Forecast
External Beam Radiation Therapy
EBRT by Technique Type
EBRT, by System Type
EBRT, by Application
Internal Beam Radiation Therapy
IBRT, by Technique Type
IBRT, by Product Type
IBRT, by Application
Radiation Therapy Market, by Region
Market Size and Forecast
North America
Europe
Asia-Pacific
Rest of the World (Row)
Radiopharmaceuticals Market, by Product Type
Market Size and Forecast
Diagnostic Radiopharmaceuticals
Therapeutic Radiopharmaceuticals
Radiopharmaceuticals Market, by Application
Market Size and Forecast
Oncology
Cardiology
Neurology
Other Applications
Radiopharmaceuticals Market, by Production Method
Market Overview
Nuclear Reactors
Cyclotrons
Radionuclide Generators
Market Size and Forecast
Geographic Breakdown
Radiopharmaceuticals Market, by Region
Market Size and Forecast
North America
Europe
Asia-Pacific
RoW

Chapter 6 Competitive Intelligence

Leading Radiotherapy Device Manufacturers
Leading Companies in Radiopharmaceuticals

Chapter 7 Appendix

Methodology
Sources
Abbreviations
Company Profiles
ACCURAY INC.
CARDINAL HEALTH
CURIUM
ELEKTA
GE HEALTHCARE
LANTHEUS
NOVARTIS AG
SIEMENS HEATHNIEERS AG

簡介目錄圖表

List of Tables

Summary Table : Global Market for Radiation Therapy Products and Radiopharmaceuticals, by Type, Through 2029
Table 1 : Acquisitions and Funding in the Radiopharmaceuticals Market
Table 2 : Comparison of CT and MRI for Radiotherapy Treatment
Table 3 : Targeted Alpha Therapies in Development, 2024
Table 4 : Global Market for Radiation Therapy Products and Services, by Product Type, Through 2029
Table 5 : Global Market for Radiation Therapy Products and Services, by Technology Type, Through 2029
Table 6 : Global Market for EBRT Products and Services, by Technique Type, Through 2029
Table 7 : Specialized Stereotactic Radiosurgery Systems
Table 8 : Global Market for EBRT Products and Services, by System Type, Through 2029
Table 9 : Global Market for Particle Therapy Products and Services, by System Type, Through 2029
Table 10 : Global Market for EBRT Products and Services, by Application, Through 2029
Table 11 : Estimated Number of New Cancer Cases, by Cancer Site, 2022-2045
Table 12 : Commonly Used Radionuclides (Radiation Sources) Half-Life for Brachytherapy
Table 13 : Global Market for Internal Radiation Therapy Products and Services, by Technique Type, Through 2029
Table 14 : Global Market for Internal Radiation Therapy Products and Services, by Product Type, Through 2029
Table 15 : Estimated New Cancer Cases, by Cancer Site, 2022-2045
Table 16 : Global Market for Internal Beam Radiation Therapy Products and Services, by Application, Through 2029
Table 17 : Global Market for Radiation Therapy Products and Services, by Region, Through 2029
Table 18 : North American Market for Radiation Therapy Products and Services, by Product Type, Through 2029
Table 19 : North American Market for Radiation Therapy Products and Services, by Country, Through 2029
Table 20 : North American Market for Radiotherapy Products and Services, by Technology Type, Through 2029
Table 21 : North American Market for EBRT Products and Services, by System Type, Through 2029
Table 22 : North American Market for Internal Radiation Therapy Products and Services, by Product Type, Through 2029
Table 23 : European Market for Radiation Therapy Products and Services, by Product Type, Through 2029
Table 24 : European Market for Radiation Therapy Products and Services, by Country, Through 2029
Table 25 : European Market for Radiotherapy Products and Services, by Technology Type, Through 2029
Table 26 : European Market for EBRT Products and Services, by System Type, Through 2029
Table 27 : European Market for Internal Radiation Therapy Products and Services, by Product Type, Through 2029
Table 28 : Asia-Pacific Market for Radiation Therapy Products and Services, by Product Type, Through 2029
Table 29 : Asia-Pacific Market for Radiation Therapy Products and Services, by Country, Through 2029
Table 30 : Asia-Pacific Market for Radiotherapy Products and Services, by Technology Type, Through 2029
Table 31 : Asia-Pacific Market for EBRT Products and Services, by System Type, Through 2029
Table 32 : Asia-Pacific Market for Internal Radiation Therapy Products and Services, by Product Type, Through 2029
Table 33 : Global Cancer Incidence, by Region, 2022 and 2045
Table 34 : RoW Market for Radiation Therapy Products and Services, by Product Type, Through 2029
Table 35 : RoW Market for Radiation Therapy Products and Services, by Subregion, Through 2029
Table 36 : RoW Market for Radiotherapy Products and Services, by Technology Type, Through 2029
Table 37 : RoW Market for EBRT Products and Services, by System Type, Through 2029
Table 38 : RoW Market for Internal Radiation Therapy Products and Services, by Product Type, Through 2029
Table 39 : Global Market for Radiopharmaceuticals, by Product Type, Through 2029
Table 40 : Radioisotopes Used in Diagnostic Radiopharmaceuticals
Table 41 : Comparison of PET and SPECT
Table 42 : FDA-approved PET Radiopharmaceuticals
Table 43 : FDA-approved SPECT and Other Diagnostic Radiopharmaceuticals
Table 44 : Global Market for Diagnostic Radiopharmaceuticals, by Product Type, Through 2029
Table 45 : Comparison of Alpha and Beta Particles
Table 46 : FDA-approved Therapeutic Radiopharmaceuticals
Table 47 : Global Market for Therapeutic Radiopharmaceuticals, by Product Type, Through 2029
Table 48 : Global Market for Radiopharmaceuticals, by Application, Through 2029
Table 49 : Radiopharmaceuticals for CNS Imaging in Clinical Development
Table 50 : Global Market for Radiopharmaceuticals, by Production Method, Through 2029
Table 51 : Global Market for Radiopharmaceuticals, by Region, Through 2029
Table 52 : North American Market for Radiopharmaceuticals, by Product Type, Through 2029
Table 53 : European Market for Radiopharmaceuticals, by Product Type, Through 2029
Table 54 : Asia-Pacific Market for Radiopharmaceuticals, by Product Type, Through 2029
Table 55 : RoW Market for Radiopharmaceuticals, by Product Type, Through 2029
Table 56 : Rank of Companies in the Global Radiopharmaceuticals Market, 2023
Table 57 : Report Sources
Table 58 : Abbreviations Used in This Report
Table 59 : Accuray Inc.: Company Snapshot
Table 60 : Accuray Inc.: Financial Performance, FY 2022 and 2023
Table 61 : Accuray Inc.: Product Portfolio
Table 62 : Accuray Inc.: News/Key Developments, 2022 and 2023
Table 63 : Cardinal Health: Company Snapshot
Table 64 : Cardinal Health: Financial Performance, FY 2022 and 2023
Table 65 : Cardinal Health: Product Portfolio
Table 66 : Cardinal Health: News/Key Developments, 2021
Table 67 : Curium: Company Snapshot
Table 68 : Curium: Product Portfolio
Table 69 : Curium: News/Key Developments, 2022 and 2023
Table 70 : Elekta: Company Snapshot
Table 71 : Elekta: Financial Performance, FY 2021 and FY 2022
Table 72 : Elekta: Product Portfolio
Table 73 : Elekta: News/Key Developments, 2021-2023
Table 74 : GE HealthCare: Company Snapshot
Table 75 : GE HealthCare: Financial Performance, FY 2022 and 2023
Table 76 : GE HealthCare: Product Portfolio
Table 77 : GE HealthCare: News/Key Developments, 2021-2023
Table 78 : Lantheus: Company Snapshot
Table 79 : Lantheus: Financial Performance, FY 2022 and 2023
Table 80 : Lantheus: Product Portfolio
Table 81 : Lantheus: News/Key Developments, 2022 and 2023
Table 82 : Novartis AG: Company Snapshot
Table 83 : Novartis AG: Financial Performance, FY 2022 and 2023
Table 84 : Novartis AG: Product Portfolio
Table 85 : Novartis AG: News/Key Developments, 2022 and 2023
Table 86 : Siemens Healthineers AG: Company Snapshot
Table 87 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
Table 88 : Siemens Healthineers AG: Product Portfolio
Table 89 : Siemens Healthineers AG: News/Key Developments, 2022-2024

List of Figures

Summary Figure : Global Market for Radiation Therapy Products and Radiopharmaceuticals, by Type, 2021-2029
Figure 1 : Types of Radiation
Figure 2 : Radiation Therapy and Radiopharmaceuticals Market Dynamics
Figure 3 : Estimated New Cancer Cases, 2022, 2045 and 2050
Figure 4 : Cancer Radiotherapy Treatment Systems, by Region, 2021
Figure 5 : Global Incidence of Cancer, by Region, 2022 and 2045
Figure 6 : Global Market Shares of Radiation Therapy Products and Services, by Product Type, 2023
Figure 7 : Global Market Shares of Radiation Therapy Products and Services, by Technology Type, 2023
Figure 8 : Global Market Shares of EBRT Products and Services, by Technique Type, 2023
Figure 9 : Global Market Shares of EBRT Products and Services, by System Type, 2023
Figure 10 : Global Market Shares of Particle Therapy Products and Services, by System Type, 2023
Figure 11 : Global Market Shares of EBRT Products and Services, by Application, 2023
Figure 12 : Global Market Shares of Internal Radiation Therapy Products and Services, by Technique Type, 2023
Figure 13 : Global Market Shares of Internal Radiation Therapy Products and Services, by Product Type, 2023
Figure 14 : Global Market Shares of Internal Radiation Therapy Products and Services, by Application, 2023
Figure 15 : Global Market for Radiation Therapy Products and Services, by Region, 2021-2029
Figure 16 : Global Market Shares of Radiation Therapy Products and Services, by Region, 2023
Figure 17 : Global Market Shares of Radiopharmaceuticals, by Product Type, 2023
Figure 18 : Global Market Shares of Diagnostic Radiopharmaceuticals, by Product Type, 2023
Figure 19 : Global Market Shares of Therapeutic Radiopharmaceuticals, by Product Type, 2023
Figure 20 : Global Market Shares of Radiopharmaceuticals, by Application, 2023
Figure 21 : Global Market Shares of Radiopharmaceuticals, by Production Method, 2023
Figure 22 : Global Market Shares of Radiopharmaceuticals, by Region, 2023
Figure 23 : North American Market Shares of Radiopharmaceuticals, by Product Type, 2023
Figure 24 : European Market Shares of Radiopharmaceuticals, by Product Type, 2023
Figure 25 : Asia-Pacific Market Shares of Radiopharmaceuticals, by Product Type, 2023
Figure 26 : RoW Market Shares of Radiopharmaceuticals, by Product Type, 2023
Figure 27 : Global Market Shares of Radiation Therapy Devices, by Company, 2023
Figure 28 : Global Market Shares of Radiopharmaceuticals, by Company, 2023
Figure 29 : Accuray Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 30 : Accuray Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 31 : Cardinal Health: Revenue Shares, by Business Unit, FY 2023
Figure 32 : Cardinal Health: Revenue Shares, by Country/Region, FY 2023
Figure 33 : Elekta: Revenue Shares, by Business Unit, FY 2022
Figure 34 : Elekta: Revenue Shares, by Country/Region, FY 2022
Figure 35 : GE HealthCare: Revenue Shares, by Business Unit, FY 2023
Figure 36 : GE HealthCare: Revenue Shares, by Country/Region, FY 2023
Figure 37 : Lantheus: Revenue Shares, by Business Unit, FY 2023
Figure 38 : Novartis AG: Revenue Shares, by Business Unit, FY 2023
Figure 39 : Novartis AG: Revenue Shares, by Country/Region, FY 2023
Figure 40 : Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2023
Figure 41 : Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2023